# Direct Complete Versus Staged Complete Revascularization in Patients Presenting With Acute Coronary Syndromes and Multivessel Disease

> **NCT03621501** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Erasmus Medical Center** · enrollment: 1525 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DEVICE:** Percutaneous coronary intervention

## Key facts

- **NCT ID:** NCT03621501
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-06-22
- **Primary completion:** 2022-10-31
- **Final completion:** 2026-10-31
- **Target enrollment:** 1525 (ACTUAL)
- **Last updated:** 2022-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03621501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03621501, "Direct Complete Versus Staged Complete Revascularization in Patients Presenting With Acute Coronary Syndromes and Multivessel Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03621501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*